3 Biotech Stocks Where Momentum is Alive and Well

Take a swing for the fences with these three rising stars

      View All  
3 Biotech Stocks Where Momentum is Alive and Well

Questcor Pharmaceuticals

 3 Biotech Stocks Where Momentum is Alive and Well Like Regeneron, Questcor (QCOR) should benefit from the growth of an existing product, Acthar Gel. This one took a pause at the end of year on questions surrounding marketing practices – specifically improper payments to doctors.

Putting that aside for a moment, the value here is compelling. Analysts expect the company to grow profits in 2014 by 23%. At current prices, shares trade for only 8 times earnings.

What you ultimately have with Questcor are two very strong, opposing forces. Shorts will take questions about the marketing and claim fraud hoping to push shares lower. Longs will see further expansion of the company’s products and the low valuation. I’d bet on the momentum longs here.


Article printed from InvestorPlace Media, http://investorplace.com/2014/01/biotech-stocks-to-buy-regn-qcor-ebs/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.